10x Genomics, Inc.
TXG
Key stats
- Open
- 57.87
- Day high
- 60.37
- Day low
- 53.00
- Previous close
- 62.05
- Volume
- 2.74M
- VWAP
- 58.41
- 52-week high
- 102.81
- 52-week low
- 15.12
- Market cap
- 8.16B
- Shares out
- 120.21M
- Employees
- 1,178
- Listed
- 2019
About 10x Genomics, Inc.
10x Genomics Inc is a life science technology company based in the United States. Its solutions include instruments, consumables, and software for analyzing biological systems. The company's integrated solutions include instruments, consumables, and software for analyzing biological systems at a resolution and scale that matches the complexity of biology. Its product offerings include a Chromium platform comprising microfluidic chips and related consumables, Chromium X series, Visium and Xenium platforms, and others, which are predominantly used for the study of biological components. Geographically, the company derives operates from the United States and the rest from Americas (excluding the United States), Europe, Middle East and Africa, China, and Asia-Pacific (excluding China).
LABORATORY ANALYTICAL INSTRUMENTS · PLEASANTON, CA · 10xgenomics.com
Options · expiring Nov 20
Nov 12, 4:00 PM ET- Call open interest
- 2.7K
- Put open interest
- 2.3K
- Put/call
- 0.83
- At-the-money IV
- 69.5%
| Contract | Last | Traded | Volume | Open int. | IV |
|---|---|---|---|---|---|
| 55 call | 5.32 | Nov 12, 3:32 PM | 29 | 41 | 99.5% |
| 50 put | 0.40 | Nov 12, 3:57 PM | 16 | 412 | 120.0% |
| 60 call | 3.10 | Nov 12, 3:29 PM | 11 | 326 | 69.5% |
| 50 call | 10.10 | Nov 12, 2:34 PM | 10 | 122 | 104.1% |
| 70 call | 0.55 | Nov 12, 3:58 PM | 9 | 2.0K | 96.2% |
| 65 call | 1.26 | Nov 12, 11:29 AM | 5 | 285 | 93.9% |
Quarterly results
Massive · Aug 7, 2026| Q2 2026 to Jun 30, 2026 | Q1 2026 to Mar 31, 2026 | Q4 2025 to Dec 31, 2025 | Q3 2025 to Sep 30, 2025 | |
|---|---|---|---|---|
| Revenue | $151.04M | $150.84M | $166.03M | $149.00M |
| Gross profit | $112.50M | $106.18M | $113.05M | $100.31M |
| Operating income | −$19.55M | −$17.05M | −$19.54M | −$32.24M |
| Net income | −$17.93M | −$13.47M | −$16.25M | −$27.47M |
| Diluted EPS | -0.14 | -0.10 | -0.13 | -0.22 |
| Operating cash flow | $16.97M | $26.12M | $40.78M | $43.21M |
| Assets | $1.03B | $1.02B | $1.04B | $1.03B |
| Liabilities | $204.52M | $201.44M | $245.04M | $242.24M |
| Equity | $825.55M | $814.32M | $796.33M | $785.12M |
Technicals
Massive · Nov 12, 2026- 50-day average74.02
- 200-day average42.39
- RSI (14 days)39.9
Short interest
Massive · Oct 30, 2026- Oct 30, 202612.47M shares · 4.1 days to cover
- Oct 15, 202612.73M shares · 2.6 days to cover
- Sep 30, 202615.37M shares · 4.5 days to cover
- Sep 15, 202616.69M shares · 7.1 days to cover
Related companies
MassiveNews coverage
No stories about 10x Genomics, Inc. right now.